JP · biotech · gene therapy
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Oct 2025 · $7.2M
Japan’s AMED (Japan Agency for Medical Research and Development), Venture capital firms
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.